Clinical Trial Update: Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of liposomal doxorubicin and docetaxel for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED